Cargando…
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
Muscle-invasive bladder cancer (MIBC) is an aggressive disease with limited therapeutic options. Although immunotherapies are approved for MIBC, the majority of patients fail to respond, suggesting existence of complementary immune evasion mechanisms. Here, we report that the PPARγ/RXRα pathway cons...
Autores principales: | Korpal, Manav, Puyang, Xiaoling, Jeremy Wu, Zhenhua, Seiler, Roland, Furman, Craig, Oo, Htoo Zarni, Seiler, Michael, Irwin, Sean, Subramanian, Vanitha, Julie Joshi, Jaya, Wang, Chris K., Rimkunas, Victoria, Tortora, Davide, Yang, Hua, Kumar, Namita, Kuznetsov, Galina, Matijevic, Mark, Chow, Jesse, Kumar, Pavan, Zou, Jian, Feala, Jacob, Corson, Laura, Henry, Ryan, Selvaraj, Anand, Davis, Allison, Bloudoff, Kristjan, Douglas, James, Kiss, Bernhard, Roberts, Morgan, Fazli, Ladan, Black, Peter C., Fekkes, Peter, Smith, Peter G., Warmuth, Markus, Yu, Lihua, Hao, Ming-Hong, Larsen, Nicholas, Daugaard, Mads, Zhu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524640/ https://www.ncbi.nlm.nih.gov/pubmed/28740126 http://dx.doi.org/10.1038/s41467-017-00147-w |
Ejemplares similares
-
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
por: Korpal, Manav, et al.
Publicado: (2019) -
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex
por: Teng, Teng, et al.
Publicado: (2017) -
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
por: Korpal, Manav, et al.
Publicado: (2015) -
Real-time and label free determination of ligand binding-kinetics to primary cancer tissue specimens; a novel tool for the assessment of biomarker targeting
por: Clausen, Thomas Mandel, et al.
Publicado: (2016) -
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators
por: Aird, Daniel, et al.
Publicado: (2019)